PURPOSE To report on the efficacy and safety of combined phacoemulsification and an Ahmed valve glaucoma drainage implant with respect to visual acuity improvement, intraocular pressure (IOP) control, and requirement for antiglaucoma medication. METHODS A retrospective chart review was conducted of 41 eyes (31 patients) with coexisting visually significant cataracts and uncontrolled glaucoma ...

Aims—To evaluate the eYcacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucomas. Methods—This retrospective study reviewed the final intraocular pressure, visual outcome, and incidence of complications in all patients with the Ahmed glaucoma valve implant performed at the Prince of Wales Hospital, Hong Kong, between June 1996 and November 1998. Results—A to...

We describe the Molteno3 glaucoma implant, its design principles and the differences and similarities with the current generation of Molteno implant. Clinical results from 37 Molteno3 implant procedures for primary open angle glaucoma are compared with a control group of 33 pressureridge single plate Molteno implants. The results obtained in cases of primary open angle glaucoma, neovascular gla...

AIMS To assess the intraocular pressure (IOP) lowering mechanism of deep sclerectomy with collagen implant (DSCI), a non-penetrating glaucoma surgery. METHODS Nine eyes of nine patients with medically uncontrolled open angle glaucoma underwent DSCI. Ultrasound biomicroscopy (UBM) of the sclerectomy site was performed 1 month after surgery. The following factors were assessed: length and heigh...

OBJECTIVE To evaluate the effect of adjunctive intravitreal triamcinolone (IVTA) on intraocular pressure (IOP) in the setting of combined vitrectomy with phacoemulsification. DESIGN Retrospective case series. PARTICIPANTS One hundred thirty-one consecutive eyes undergoing nonemergent vitrectomy with phacoemulsification and IVTA were reviewed and included in the analysis. All 131 eyes receiv...

OBJECTIVE To compare 2 commonly used aqueous drainage devices for the treatment of refractory glaucoma. DESIGN International, multicenter, randomized trial. PARTICIPANTS Patients aged 18 years or older with uncontrolled or high-risk glaucoma refractory to maximum medical therapy, many of whom had failed trabeculoplasty and trabeculectomy. METHODS Eligible patients were randomized to an Ah...